You just read:

Cipher Pharmaceuticals Announces Preliminary Q2 2016 Results Highlighted by 30+% Revenue Growth and $3.0+million Cash from Operations

News provided by

Cipher Pharmaceuticals Inc.

03 Aug, 2016, 08:51 ET